Trader Mind Medicine (MindMed) Inc. Subordinate Voting Shares - MNMD CFD
Ajouter aux favoris- Résumé
- Données historiques
- Événements
- Compte de résultat
- Bilan
- Flux de trésorerie
- Capital
Écart | 0.05 | ||||||||
Frais de position longue en overnight
Long position overnight fee
Aller vers la plateforme | -0.025457% | ||||||||
Frais de position courte en overnight
Short position overnight fee
Aller vers la plateforme | 0.003235% | ||||||||
Durée des frais en overnight | 21:00 (UTC) | ||||||||
Quantité minimale négociée | 0.01 | ||||||||
Devise | USD | ||||||||
Marge | 20% | ||||||||
Bourse | United States of America | ||||||||
Commission sur la négociation | 0% |
*Information provided by Capital.com
Mind Medicine (MindMed) Inc ESG Risk Ratings
‘D’ score indicates poor relative ESG performance and insufficient degree of transparency in reporting material ESG data publicly.
Fermeture précédente* | 3.5 |
Ouvert* | 3.49 |
Variation sur 1 an* | 283.52% |
Fourchette du jour* | 3.37 - 3.5 |
Fourchette sur 52 semaines | 2.88-25.65 |
Volume moyen (10 jours) | 18.57K |
Volume moyen (3 mois) | 482.52K |
Capitalisation boursière | 184.87M |
Ratio C/B | -100.00K |
Actions en circulation | 38.60M |
Revenu | N/A |
EPS | -2.64 |
Dividende (rendement en %) | N/A |
Bêta | 2.12 |
Prochaine date de publication des résultats | Aug 9, 2023 |
Toutes les données sont fournies par Refinitiv, à l'exception des données marquées d'un astérisque, qui sont des *données fournies par Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Clôture | Change | Change (%) | Ouverture | High | Low |
---|---|---|---|---|---|---|
Jun 1, 2023 | 3.50 | 0.08 | 2.34% | 3.42 | 3.53 | 3.41 |
May 31, 2023 | 3.51 | -0.05 | -1.40% | 3.56 | 3.64 | 3.39 |
May 30, 2023 | 3.61 | 0.10 | 2.85% | 3.51 | 3.65 | 3.49 |
May 26, 2023 | 3.49 | 0.25 | 7.72% | 3.24 | 3.55 | 3.23 |
May 25, 2023 | 3.31 | -0.07 | -2.07% | 3.38 | 3.43 | 3.26 |
May 24, 2023 | 3.39 | -0.05 | -1.45% | 3.44 | 3.49 | 3.32 |
May 23, 2023 | 3.45 | -0.06 | -1.71% | 3.51 | 3.68 | 3.43 |
May 22, 2023 | 3.55 | 0.23 | 6.93% | 3.32 | 3.57 | 3.29 |
May 19, 2023 | 3.32 | 0.12 | 3.75% | 3.20 | 3.38 | 3.18 |
May 18, 2023 | 3.12 | 0.01 | 0.32% | 3.11 | 3.30 | 3.08 |
May 17, 2023 | 3.11 | 0.13 | 4.36% | 2.98 | 3.13 | 2.94 |
May 16, 2023 | 3.00 | -0.05 | -1.64% | 3.05 | 3.09 | 2.98 |
May 15, 2023 | 3.13 | 0.14 | 4.68% | 2.99 | 3.16 | 2.98 |
May 12, 2023 | 3.02 | -0.02 | -0.66% | 3.04 | 3.07 | 2.98 |
May 11, 2023 | 3.05 | -0.08 | -2.56% | 3.13 | 3.19 | 3.03 |
May 10, 2023 | 3.16 | -0.12 | -3.66% | 3.28 | 3.31 | 3.16 |
May 9, 2023 | 3.26 | -0.01 | -0.31% | 3.27 | 3.35 | 3.22 |
May 8, 2023 | 3.36 | 0.03 | 0.90% | 3.33 | 3.37 | 3.20 |
May 5, 2023 | 3.36 | -0.11 | -3.17% | 3.47 | 3.56 | 3.30 |
May 4, 2023 | 3.58 | 0.04 | 1.13% | 3.54 | 3.61 | 3.50 |
Mind Medicine (MindMed) Inc. Subordinate Voting Shares Events
Heure (UTC) (UTC) | Pays | Événement |
---|---|---|
Monday, June 5, 2023 | ||
Heure (UTC) (UTC) 19:30 | Pays CA
| Événement Mind Medicine (MindMed) Inc at Biotechnology Industry Organization (BIO) International Convention Mind Medicine (MindMed) Inc at Biotechnology Industry Organization (BIO) International ConventionForecast -Previous - |
Thursday, June 15, 2023 | ||
Heure (UTC) (UTC) 14:00 | Pays CA
| Événement Mind Medicine (MindMed) Inc Annual Shareholders Meeting Mind Medicine (MindMed) Inc Annual Shareholders MeetingForecast -Previous - |
Wednesday, August 9, 2023 | ||
Heure (UTC) (UTC) 10:59 | Pays CA
| Événement Q2 2023 Mind Medicine (MindMed) Inc Earnings Release Q2 2023 Mind Medicine (MindMed) Inc Earnings ReleaseForecast -Previous - |
Wednesday, November 8, 2023 | ||
Heure (UTC) (UTC) 13:30 | Pays CA
| Événement Q3 2023 Mind Medicine (MindMed) Inc Earnings Release Q3 2023 Mind Medicine (MindMed) Inc Earnings ReleaseForecast -Previous - |
- Annuel
- Trimestriel
2022 | 2021 | 2020 | 2019 | 2019 | |
---|---|---|---|---|---|
Revenu total | 0 | 0 | 0 | 0 | 0 |
Total des frais d'exploitation | 66.331 | 93.854 | 33.03 | 1.10477 | 5.42921 |
Total des frais de vente/Généraux/Admin | 30.162 | 59.065 | 14.399 | 0.456936 | 3.10517 |
Recherche et développement | 32.969 | 34.789 | 18.631 | 2.04904 | |
Depreciation / Amortization | 3.2 | 0.006618 | 0.275 | ||
Intérêts débiteurs (produits) - Résultat net d'exploitation | |||||
Produits d'exploitation | -66.331 | -93.854 | -33.03 | -1.10477 | -5.42921 |
Produits (charges) d'intérêts, nets Hors exploitation | 1.69 | -0.445 | -0.907 | 0 | 0.02751 |
Autres, nets | 7.845 | 0.106 | 0 | -0.0725 | |
Résultat net avant impôts | -56.796 | -94.193 | -33.937 | -1.10477 | -5.47421 |
Résultat net après impôts | -56.796 | -93.036 | -33.937 | -1.10477 | -5.47421 |
Résultat net avant éléments extra | -56.796 | -93.036 | -33.937 | -1.10477 | -5.47421 |
Résultat net | -56.796 | -93.036 | -33.937 | -1.10477 | -5.47421 |
Revenu disponible pour les actionnaires ordinaires, hors éléments exceptionnels | -56.796 | -93.036 | -33.937 | -1.10477 | -5.47421 |
Bénéfice disponible pour les actionnaires ordinaires, y compris les éléments exceptionnels | -56.796 | -93.036 | -33.937 | -1.10477 | -5.47421 |
Résultat net dilué | -56.796 | -93.036 | -33.937 | -1.10477 | -5.47421 |
Moyenne pondérée des actions diluées | 30.8575 | 27.3785 | 17.7489 | 0.37943 | 6.92954 |
BPA dilué hors éléments extraordinaires | -1.84059 | -3.39815 | -1.91206 | -2.91167 | -0.78998 |
BPA dilué normalisé | -1.84059 | -3.39815 | -1.91206 | -1.22171 | -0.78998 |
Charges (revenus) inhabituelles | 0.641219 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Revenu total | 0 | 0 | 0 | 0 | 0 |
Total des frais d'exploitation | 20.862 | 13.9 | 16.983 | 16.943 | 18.505 |
Total des frais de vente/Généraux/Admin | 8.263 | 5.07 | 9.211 | 7.617 | 8.264 |
Recherche et développement | 11.799 | 8.03 | 6.972 | 8.526 | 9.441 |
Produits d'exploitation | -20.862 | -13.9 | -16.983 | -16.943 | -18.505 |
Produits (charges) d'intérêts, nets Hors exploitation | 1.232 | 1.153 | 0.498 | -0.007 | 0.018 |
Autres, nets | -5.185 | 7.844 | 0 | -0.007 | 0.036 |
Résultat net avant impôts | -24.815 | -4.903 | -16.485 | -16.957 | -18.451 |
Résultat net après impôts | -24.815 | -4.903 | -16.485 | -16.957 | -18.451 |
Résultat net avant éléments extra | -24.815 | -4.903 | -16.485 | -16.957 | -18.451 |
Résultat net | -24.815 | -4.903 | -16.485 | -16.957 | -18.451 |
Revenu disponible pour les actionnaires ordinaires, hors éléments exceptionnels | -24.815 | -4.903 | -16.485 | -16.957 | -18.451 |
Bénéfice disponible pour les actionnaires ordinaires, y compris les éléments exceptionnels | -24.815 | -4.903 | -16.485 | -16.957 | -18.451 |
Résultat net dilué | -24.815 | -4.903 | -16.485 | -16.957 | -18.451 |
Moyenne pondérée des actions diluées | 38.0773 | 37.7314 | 29.2963 | 28.2434 | 28.1489 |
BPA dilué hors éléments extraordinaires | -0.6517 | -0.12994 | -0.5627 | -0.60039 | -0.65548 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
BPA dilué normalisé | -0.6517 | -0.12994 | -0.5627 | -0.60039 | -0.65548 |
Depreciation / Amortization | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 |
Charges (revenus) inhabituelles |
- Annuel
- Trimestriel
2022 | 2021 | 2020 | 2019 | 2019 | |
---|---|---|---|---|---|
Total de l'actif à court terme | 146.055 | 137.215 | 81.519 | 2.91521 | 6.73654 |
Espèces et placements à court terme | 142.142 | 133.539 | 80.094 | 0.017801 | 3.01645 |
Trésorerie et équivalents | 0.017801 | ||||
Investissements à court terme | |||||
Total des créances, nettes | 0.005042 | ||||
Prepaid Expenses | 3.913 | 3.676 | 1.425 | 0.021357 | 0.0342 |
Total Assets | 169.993 | 164.002 | 81.519 | 2.91521 | 11.9615 |
Property/Plant/Equipment, Total - Net | 0 | ||||
Other Long Term Assets, Total | 0.331 | 0 | |||
Total Current Liabilities | 17.892 | 10.408 | 3.008 | 0.143617 | 1.9612 |
Accounts Payable | 2.111 | 4.178 | 2.022 | 0.143617 | 1.9612 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 19.076 | 12.338 | 5.651 | 0.19749 | 1.9612 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Total Equity | 150.917 | 151.664 | 75.868 | 2.71772 | 10.0003 |
Common Stock | 0 | 0 | 5.51407 | 15.3218 | |
Additional Paid-In Capital | 344.758 | 288.29 | 120.22 | 0.792485 | |
Retained Earnings (Accumulated Deficit) | -194.468 | -137.672 | -44.636 | -3.62328 | -5.32143 |
Other Equity, Total | 0.627 | 1.046 | 0.284 | 0.034436 | |
Total Liabilities & Shareholders’ Equity | 169.993 | 164.002 | 81.519 | 2.91521 | 11.9615 |
Total Common Shares Outstanding | 37.9791 | 28.1022 | 20.96 | 0.40552 | 11.0999 |
Other Liabilities, Total | 1.184 | 1.93 | 2.643 | 0.053873 | 0 |
Other Current Assets, Total | 2.87101 | 3.6859 | |||
Cash | 142.142 | 133.539 | 80.094 | 3.01645 | |
Intangibles, Net | 3.689 | 6.869 | 0 | 5.225 | |
Goodwill, Net | 19.918 | 19.918 | 0 | ||
Accrued Expenses | 5.877 | 6.23 | 0.986 | ||
Other Current Liabilities, Total | 9.904 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Total de l'actif à court terme | 132.413 | 146.055 | 156.51 | 109.09 | 123.227 |
Espèces et placements à court terme | 129.409 | 142.142 | 154.519 | 105.741 | 120.472 |
Cash | 129.409 | 142.142 | 154.519 | 105.741 | 120.472 |
Prepaid Expenses | 3.004 | 3.913 | 1.826 | 3.172 | 2.755 |
Other Current Assets, Total | 0.165 | 0.177 | |||
Total Assets | 155.529 | 169.993 | 180.907 | 134.277 | 149.234 |
Property/Plant/Equipment, Total - Net | |||||
Goodwill, Net | 19.918 | 19.918 | 19.918 | 19.918 | 19.918 |
Intangibles, Net | 2.898 | 3.689 | 4.479 | 5.269 | 6.089 |
Total Current Liabilities | 24.096 | 17.892 | 26.038 | 7.871 | 10.559 |
Accounts Payable | 2.32 | 2.111 | 0.824 | 0.732 | 3.332 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 25.185 | 19.076 | 27.314 | 9.773 | 12.429 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Deferred Income Tax | |||||
Total Equity | 130.344 | 150.917 | 153.593 | 124.504 | 136.805 |
Common Stock | 0 | 0 | 0 | 0 | 0 |
Additional Paid-In Capital | 348.986 | 344.758 | 342.415 | 296.734 | 291.931 |
Retained Earnings (Accumulated Deficit) | -219.283 | -194.468 | -189.565 | -173.08 | -156.123 |
Other Equity, Total | 0.641 | 0.627 | 0.743 | 0.85 | 0.997 |
Total Liabilities & Shareholders’ Equity | 155.529 | 169.993 | 180.907 | 134.277 | 149.234 |
Total Common Shares Outstanding | 38.2901 | 37.9791 | 37.5411 | 28.4474 | 28.1615 |
Accrued Expenses | 6.687 | 5.877 | 7.467 | 7.139 | 7.227 |
Other Liabilities, Total | 1.089 | 1.184 | 1.276 | 1.902 | 1.87 |
Other Current Liabilities, Total | 15.089 | 9.904 | 17.747 | ||
Other Long Term Assets, Total | 0.3 | 0.331 |
- Annuel
- Trimestriel
2022 | 2021 | 2020 | 2019 | 2019 | |
---|---|---|---|---|---|
Revenu net/Ligne de départ | -56.796 | -93.036 | -33.937 | -1.10477 | -5.47421 |
Liquidités provenant des activités d'exploitation | -50.139 | -45.824 | -23.597 | -0.206066 | -3.19971 |
Liquidités provenant des activités d'exploitation | 0.006618 | ||||
Éléments non monétaires | 7.079 | 42.716 | 8.279 | 0.686323 | 0.0725 |
Variation du fonds de roulement | -3.602 | 3.037 | 2.061 | 0.205774 | 1.927 |
Flux de trésorerie liés aux activités d'investissement | 0 | -0.297 | 0 | -0.211048 | |
Dépenses d'investissement | -0.310361 | ||||
Autres éléments de flux de trésorerie d'investissement, total | 0 | -0.297 | 0 | 0.099313 | |
Flux de trésorerie provenant des activités de financement | 59.051 | 98.824 | 96.704 | 0.285516 | 9.90205 |
Émission (remboursement) d'actions, nette | 59.458 | 98.824 | 97.099 | 0.285516 | 9.90205 |
Émission (remboursement) de la dette, nette | 0 | ||||
Effets de change | -0.309 | 0.742 | 0.284 | -0.001382 | |
Variation nette de la trésorerie | 8.603 | 53.445 | 73.391 | -0.132972 | 6.70234 |
Amortization | 3.18 | 2.616 | 0 | 0.275 | |
Deferred Taxes | 0 | -1.157 | 0 | ||
Éléments de flux de trésorerie de financement | -0.407 | 0 | -0.395 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -24.815 | -56.796 | -51.893 | -35.408 | -18.451 |
Cash From Operating Activities | -13.331 | -50.139 | -37.29 | -27.993 | -12.866 |
Amortization | 0.791 | 3.18 | 2.39 | 1.6 | 0.78 |
Non-Cash Items | 8.967 | 7.079 | 13.861 | 8.062 | 3.792 |
Changes in Working Capital | 1.726 | -3.602 | -1.648 | -2.247 | 1.013 |
Cash From Investing Activities | 0 | 0 | 0 | 0 | |
Other Investing Cash Flow Items, Total | 0 | 0 | 0 | 0 | |
Cash From Financing Activities | 0.583 | 59.051 | 58.635 | 0.424 | -0.166 |
Financing Cash Flow Items | 0 | -0.407 | -0.407 | -0.407 | -0.407 |
Issuance (Retirement) of Stock, Net | 0.583 | 59.458 | 59.042 | 0.831 | 0.241 |
Foreign Exchange Effects | 0.015 | -0.309 | -0.365 | -0.229 | -0.035 |
Net Change in Cash | -12.733 | 8.603 | 20.98 | -27.798 | -13.067 |
Capital Expenditures | |||||
Deferred Taxes | 0 |
Pourquoi choisir capital.com? Nos chiffres parlent d'eux-mêmes.
Capital.com Group535K+
Tradeurs
87K+
Clients actifs par mois
$113M+
Volume d'investissement par mois
$64M+
Retrait par mois
Trading calculator
Calculez votre P&L hypothétique si vous aviez ouvert une transaction CFD à une certaine date (sélectionnez une date) et l'aviez fermée à une autre date (sélectionnez une date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Industry: | Biotechnology & Medical Research (NEC) |
1166 Alberni Steet
Suite 1604
VANCOUVER
BRITISH COLUMBIA V6E 3Z3
CA
Compte de résultat
- Annual
- Quarterly
Les gens regardent aussi
Êtes-vous toujours à la recherche d'un broker de confiance?
Rejoignez les plus de 535 000 traders du monde entier qui ont choisi de trader avec Capital.com